Gain an appreciation of the scientific foundations of clinical medicine and study the scientific basis of pharmacology and the clinical trials industry.
Our intercalated BSc gives students already taking a medical or dental degree the chance to achieve an additional degree in this specialist field in just one year.
Pharmacology and Innovative Therapeutics is the study of how drugs and therapies work, and the development of new ones. As research lays bare the molecular basis of disease and treatment, medical staff and researchers need increasingly specialist knowledge in molecular and cellular biology, biochemistry and chemistry.
You’ll cover a number of specialist topics in pharmacology such as drug design, translational pharmacology, innovative therapeutics and clinical trials as well as the role of regulatory agencies in therapeutic innovation and commercial exploitation.
The programme will give you expertise in the discipline, and practical experience of laboratory research. It will enhance your understanding of drugs and prescribing, bringing benefits throughout your medical degree and clinical practice.
As part of your degree, you'll work on a research topic of your own choosing, alongside leading teams at the William Harvey Research Institute.
At Queen Mary, we have been adapting to the challenges of Covid-19 so we are ready for the new academic year, with all the academic, pastoral and community support you need to settle in and thrive. For your chosen programme of study, the result is an innovative blended learning offering, giving you access to a world-class education whether or not you can join us on campus from September. For more information, please visit our dedicated FAQ pages.
You can start your one-year intercalated Pharmacology and Innovative Therapeutics BSc after the second, third or fourth years of your MBBS, BDS or BVetMed.
· Intercalated Research Project
· Classic Papers and Current Topics in Pharmacology
· Clinical Trials and Regulatory Affairs
· Drug Design for Pharmacologists
· Translational Pharmacology and Innovative Therapeutics
Choose one from
· Biomarkers in Neuroscience
· Cancer Biology
· Molecular Basis of Personalised Medicine
· Stem Cells and Regenerative Medicine
Please note that all modules are subject to change.
An intercalated degree will broaden your studies as you gain an additional qualification.
It will also:
You'll receive approximately three hours of weekly contact time per taught module, comprising formal lectures – including from colleagues in the NHS and, in some cases, specialists from abroad.
Assessment typically includes a combination of written exams, coursework essays, journal clubs and oral presentations, and project write up.
The School offers excellent on-campus resources to aid your studies, including:
UK students accepted onto this course are eligible to apply for from Student Finance England or other government bodies.
Medical and dental students from Barts and The London will be considered for various bursaries based on research interests, financial need or academic merit.
These bursaries are not available to students from other medical schools, or to Barts and The London students who choose to intercalate externally.
We offer specialist support on all financial and welfare issues through our Advice and Counselling Service, which you can access as soon as you have applied for a place at Queen Mary.
Take a look at our Student Advice Guides which cover ways to finance your degree, including:
With its focus on pharmacological research, this programme forms a strong basis for careers in academic medicine. Your understanding of the actions of drugs and ability to evaluate the latest research will also be an advantage in any area of clinical work or within the pharmaceutical and clinical trials industry.
The William Harvey Research Institute was founded in 1986 by the Nobel Laureate Sir John Vane, discoverer of the action of aspirin and prostacyclin. Since 2000, as part of Barts and The London School of Medicine and Dentistry and Queen Mary University of London, the Institute has gone from strength to strength. We are currently the largest pharmacological research institute in the UK university sector and one of the largest in Europe.
Along with our commitment to high-quality research, we also offer education programmes at undergraduate, postgraduate and research level, which are taught by world-leading experts in the fields of cardiovascular, endocrine and inflammation research.
We are proud to have been awarded the Athena SWAN silver award for our ongoing commitment to advancing women’s careers in science, technology, engineering, mathematics and medicine.